Wound Care News

Colton Mason's picture

By Colton Mason

Medicare has recently made a significant change to several wound care dressings with honey-based components. The Medicare contractor (PDAC) which assigns reimbursement codes to wound care products made the decision to change HCPCS codes for honey-based dressings containing more than 50% medical honey to A9270. I have been working with a market leading brand in this product category, MediHoney® (Derma Sciences), to ensure everyone has the most up-to-date information regarding this recent Medicare Policy change. Here is the information that the manufacturer has compiled to help healthcare providers make educated decisions for prescribing honey-based dressings in lieu of the recent changes from Medicare:

Blog Category: 
Industry News's picture
Keywords: 

By the WoundSource Editors

Irving, TX – March 2, 2015 – GWM Products, LLC, manufacturer of the RTD® Wound Care Dressing announced today it has changed its name to Keneric Healthcare. The name change comes as part of the company's plan to continue building its presence in the advanced wound care market. Under the new Keneric Healthcare name, the company plans to expand its product offerings for the RTD Wound Dressing line and its portfolio of advanced wound care products.

Blog Category: 
Industry News's picture
Keywords: 

By the WoundSource Editors

Gaithersburg, MD – February 19, 2015 – Nuo Therapeutics, Inc. (OTCQX: NUOT), a pioneer in biodynamic therapies, today announced the initiation of a new clinical study (Au Study) that is comprised of three randomized controlled protocols that examine the efficacy of Aurix™, a biodynamic hematogel, for use in diabetic foot ulcers, venous leg ulcers and pressure ulcers (bed sores).

Blog Category: 
Industry News's picture
Keywords: 
Manukahd lite honey dressing

By the WoundSource Editors

Largo, FL – February 26, 2015 – ManukaMed USA has successfully launched an improved version of its of Manukahd lite dressings.

Blog Category: 
Temple University School of Podiatric Medicine's picture
Bloodstop iX

By Emily Keeter and James McGuire DPM, PT, CPed, FAPWHc

BloodSTOP iX is an absorbable, bioresorbable, lipophilic, animal-free hemostat, which resembles and is designed to handle like gauze. BloodSTOP iX is composed of etherized oxidized regenerated cellulose, which allows it to be 100% water-soluble with no animal-derived properties. BloodSTOP iX reduces bleeding time and accelerates blood coagulation by activating the intrinsic clotting pathway. Some of the benefits of BloodSTOP iX include its cost-effectiveness, ability to conform to different types of wounds, non-irritating woven matrix, and the reduction in hold times.

Blog Category: 
Industry News's picture
Keywords: 
McKesson Advanced Skin and Wound Care Line

By the WoundSource Editors

Richmond, VA – February 2, 2015 – McKesson Medical-Surgical has launched a comprehensive advanced skin and wound care portfolio with complimentary business and clinical support. McKesson’s advanced skin and wound care solutions range from the THERA™ Advanced Skin Care line to an assortment of advanced wound care products, including the addition of silicone adhesive foam dressings. McKesson Medical-Surgical has also created educational tools to assist caregivers in the skilled nursing, home health and other extended care markets with assessing and managing their patients’ skin and wound care needs

Blog Category: 
Temple University School of Podiatric Medicine's picture

By Rizwan Tai and James McGuire DPM, PT, CPed, FAPWHc

According to Centers for Disease Control and Prevention (CDC), the number of adults between the ages of 18-79 with newly diagnosed diabetes has more than tripled in the last 30 years. Foot ulcers are a major complication of uncontrolled diabetes, and 25% of the patients will be affected with foot ulcers in their lifetime, the majority of which lead to lower extremity amputations.

Blog Category: 
Temple University School of Podiatric Medicine's picture

By Tedman L. Tan and James McGuire DPM, PT, CPed, FAPWHc

The management of diabetic foot ulcers is becoming an increasingly significant concern with the growing population of patients with diabetes in the United States. Most amputations involving the lower extremity in patients with diabetes are preceded by foot ulcers, and in turn, lower extremity amputations are associated with a high 5-year mortality rate at around 45% among individuals with diabetes.1 Therefore, diabetic foot ulcers require special attention due to the possible life-threatening complications associated with such wounds

Blog Category: 
Temple University School of Podiatric Medicine's picture
marathon liquid skin protectant

By Peter Smith and James McGuire DPM, PT, CPed, FAPWHc

Marathon® Liquid Skin Protectant by Medline Industries, Inc. is a versatile non-stinging barrier film that provides protection for at-risk skin or damaged skin. Marathon® comes in single use applicator tubes that have a built-in sponge tip. Each tube contains enough liquid skin protectant to cover an area of 10cm. The barrier film created is breathable, flexible and durable relative to other liquid skin products.

Blog Category: 
Temple University School of Podiatric Medicine's picture

By Chinenye Queen Ezike and James McGuire DPM, PT, CPed, FAPWHc

Venous Leg Ulcers (VLUs) are the most common cause of lower extremity ulcerations, affecting about 1% of the US population. Recurrence rates for VLUs are also extremely high and ulcers can remain for weeks to years, even with appropriate treatment. More often than not, however, they are treated with inadequate compression and are complicated by poor patient compliance.

Blog Category: